1160 related articles for article (PubMed ID: 28816238)
21. CXCL12+ stromal cells as bone marrow niche for CD34+ hematopoietic cells and their association with disease progression in myelodysplastic syndromes.
Abe-Suzuki S; Kurata M; Abe S; Onishi I; Kirimura S; Nashimoto M; Murayama T; Hidaka M; Kitagawa M
Lab Invest; 2014 Nov; 94(11):1212-23. PubMed ID: 25199050
[TBL] [Abstract][Full Text] [Related]
22. Abnormal morphological and functional nature of bone marrow stromal cells provides preferential support for survival of acute myeloid leukemia cells.
Yehudai-Resheff S; Attias-Turgeman S; Sabbah R; Gabay T; Musallam R; Fridman-Dror A; Zuckerman T
Int J Cancer; 2019 May; 144(9):2279-2289. PubMed ID: 30548585
[TBL] [Abstract][Full Text] [Related]
23. TGF-β1 and CXCL12 modulate proliferation and chemotherapy sensitivity of acute myeloid leukemia cells co-cultured with multipotent mesenchymal stromal cells.
Schelker RC; Iberl S; Müller G; Hart C; Herr W; Grassinger J
Hematology; 2018 Jul; 23(6):337-345. PubMed ID: 29140182
[TBL] [Abstract][Full Text] [Related]
24. Disruption of gap junctions attenuates acute myeloid leukemia chemoresistance induced by bone marrow mesenchymal stromal cells.
Kouzi F; Zibara K; Bourgeais J; Picou F; Gallay N; Brossaud J; Dakik H; Roux B; Hamard S; Le Nail LR; Hleihel R; Foucault A; Ravalet N; Rouleux-Bonnin F; Gouilleux F; Mazurier F; Bene MC; Akl H; Gyan E; Domenech J; El-Sabban M; Herault O
Oncogene; 2020 Feb; 39(6):1198-1212. PubMed ID: 31649334
[TBL] [Abstract][Full Text] [Related]
25. Understanding of the crosstalk between normal residual hematopoietic stem cells and the leukemic niche in acute myeloid leukemia.
Batsivari A; Grey W; Bonnet D
Exp Hematol; 2021 Mar; 95():23-30. PubMed ID: 33497761
[TBL] [Abstract][Full Text] [Related]
26. Transmissible ER stress reconfigures the AML bone marrow compartment.
Doron B; Abdelhamed S; Butler JT; Hashmi SK; Horton TM; Kurre P
Leukemia; 2019 Apr; 33(4):918-930. PubMed ID: 30206307
[TBL] [Abstract][Full Text] [Related]
27. Coordinate regulation of residual bone marrow function by paracrine trafficking of AML exosomes.
Huan J; Hornick NI; Goloviznina NA; Kamimae-Lanning AN; David LL; Wilmarth PA; Mori T; Chevillet JR; Narla A; Roberts CT; Loriaux MM; Chang BH; Kurre P
Leukemia; 2015 Dec; 29(12):2285-95. PubMed ID: 26108689
[TBL] [Abstract][Full Text] [Related]
28. Chronic myelogenous leukemia cells remodel the bone marrow niche via exosome-mediated transfer of miR-320.
Gao X; Wan Z; Wei M; Dong Y; Zhao Y; Chen X; Li Z; Qin W; Yang G; Liu L
Theranostics; 2019; 9(19):5642-5656. PubMed ID: 31534508
[No Abstract] [Full Text] [Related]
29. Role of Acute Myeloid Leukemia (AML)-Derived exosomes in tumor progression and survival.
Amin AH; Sharifi LMA; Kakhharov AJ; Opulencia MJC; Alsaikhan F; Bokov DO; Majdi HS; Jawad MA; Hammid AT; Shalaby MN; Mustafa YF; Siahmansouri H
Biomed Pharmacother; 2022 Jun; 150():113009. PubMed ID: 35486974
[TBL] [Abstract][Full Text] [Related]
30. Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?
Pleyer L; Valent P; Greil R
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27355944
[TBL] [Abstract][Full Text] [Related]
31. Patient-Derived Bone Marrow Spheroids Reveal Leukemia-Initiating Cells Supported by Mesenchymal Hypoxic Niches in Pediatric B-ALL.
Balandrán JC; Dávila-Velderrain J; Sandoval-Cabrera A; Zamora-Herrera G; Terán-Cerqueda V; García-Stivalet LA; Limón-Flores JA; Armenta-Castro E; Rodríguez-Martínez A; Leon-Chavez BA; Vallejo-Ruiz V; Hassane DC; Pérez-Tapia SM; Ortiz-Navarrete V; Guzman ML; Pelayo R
Front Immunol; 2021; 12():746492. PubMed ID: 34737747
[TBL] [Abstract][Full Text] [Related]
32. Culturing patient-derived malignant hematopoietic stem cells in engineered and fully humanized 3D niches.
García-García A; Klein T; Born G; Hilpert M; Scherberich A; Lengerke C; Skoda RC; Bourgine PE; Martin I
Proc Natl Acad Sci U S A; 2021 Oct; 118(40):. PubMed ID: 34580200
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Endosteal Vascular Niche Remodeling Rescues Hematopoietic Stem Cell Loss in AML.
Duarte D; Hawkins ED; Akinduro O; Ang H; De Filippo K; Kong IY; Haltalli M; Ruivo N; Straszkowski L; Vervoort SJ; McLean C; Weber TS; Khorshed R; Pirillo C; Wei A; Ramasamy SK; Kusumbe AP; Duffy K; Adams RH; Purton LE; Carlin LM; Lo Celso C
Cell Stem Cell; 2018 Jan; 22(1):64-77.e6. PubMed ID: 29276143
[TBL] [Abstract][Full Text] [Related]
34. The effect of bone marrow mesenchymal stromal cell exosomes on acute myeloid leukemia's biological functions: a focus on the potential role of LncRNAs.
Jalilivand S; Izadirad M; Vazifeh Shiran N; Gharehbaghian A; Naserian S
Clin Exp Med; 2024 May; 24(1):108. PubMed ID: 38777995
[TBL] [Abstract][Full Text] [Related]
35. Mesenchymal stromal cells derived from acute myeloid leukemia bone marrow exhibit aberrant cytogenetics and cytokine elaboration.
Huang JC; Basu SK; Zhao X; Chien S; Fang M; Oehler VG; Appelbaum FR; Becker PS
Blood Cancer J; 2015 Apr; 5(4):e302. PubMed ID: 25860293
[TBL] [Abstract][Full Text] [Related]
36. Therapeutically targeting SELF-reinforcing leukemic niches in acute myeloid leukemia: A worthy endeavor?
Bernasconi P; Farina M; Boni M; Dambruoso I; Calvello C
Am J Hematol; 2016 May; 91(5):507-17. PubMed ID: 26822317
[TBL] [Abstract][Full Text] [Related]
37. Functional inhibition of mesenchymal stromal cells in acute myeloid leukemia.
Geyh S; Rodríguez-Paredes M; Jäger P; Khandanpour C; Cadeddu RP; Gutekunst J; Wilk CM; Fenk R; Zilkens C; Hermsen D; Germing U; Kobbe G; Lyko F; Haas R; Schroeder T
Leukemia; 2016 Mar; 30(3):683-91. PubMed ID: 26601782
[TBL] [Abstract][Full Text] [Related]
38. Histone Deacetylase Inhibitors Target the Leukemic Microenvironment by Enhancing a Nherf1-Protein Phosphatase 1α-TAZ Signaling Pathway in Osteoblasts.
Kremer KN; Dudakovic A; Hess AD; Smith BD; Karp JE; Kaufmann SH; Westendorf JJ; van Wijnen AJ; Hedin KE
J Biol Chem; 2015 Dec; 290(49):29478-92. PubMed ID: 26491017
[TBL] [Abstract][Full Text] [Related]
39. Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival.
Corradi G; Baldazzi C; Očadlíková D; Marconi G; Parisi S; Testoni N; Finelli C; Cavo M; Curti A; Ciciarello M
Stem Cell Res Ther; 2018 Oct; 9(1):271. PubMed ID: 30359303
[TBL] [Abstract][Full Text] [Related]
40. Differential niche and Wnt requirements during acute myeloid leukemia progression.
Lane SW; Wang YJ; Lo Celso C; Ragu C; Bullinger L; Sykes SM; Ferraro F; Shterental S; Lin CP; Gilliland DG; Scadden DT; Armstrong SA; Williams DA
Blood; 2011 Sep; 118(10):2849-56. PubMed ID: 21765021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
